The immediate backdrop is the active regional war that intensified in March 2026, when the United States and Israel launched coordinated strikes on Iranian nuclear-related facilities, air defenses and military infrastructure; those strikes have been followed by a series of Iranian retaliatory military moves and an expanded cycle of U.S.–Israel–Iran exchanges that remain ongoing.
That regional confrontation overlays a parallel and still-contested Israeli military campaign in Gaza that began after the Hamas-led attack of Oct.
The Trump administration approved a US$2.8 billion arms sale that supplies Israel with 60,000 one‑ton bombs, renewing debate over US munitions policy.
The Strait Times reports the decision and emphasizes that one‑ton bombs were widely used in densely populated areas of the Gaza Strip after the Hamas‑led attack on Oct 7, 2023; analysts cited in the article say the shipment may reflect an effort to replenish and stockpile before upcoming US political shifts constrain transfers.
Supporters of the transfer argue Israel needs to replenish a munition it views as operationally vital; the article reports that view is driving the specific size and scope of the package.
Critics, and the article itself, frame the sale as controversial because the same class of weapon was used in densely populated Gaza, raising questions about civilian harm tied to prior campaigns.
The Strait Times highlights analysts’ assessments that timing matters — that the Trump administration sought to complete a large transfer ahead of anticipated limits under potential future US administrations.
The reporting confines itself to those facts and expert commentary; it does not provide independent casualty counts or official US or Israeli statements defending the sale in detail. The piece therefore leaves open the exact legal and humanitarian assessments of the transfer while documenting the scale, price, and the explicit link to past use of these munitions in Gaza.